Saturday, July 23, 2016 12:40:06 PM
Read the June 8th Update again:
http://www.bielcorp.com/bioelectronics-company-update-june-8-2016/
1. If a second FDA meeting was requested by BIEL at that time, why didn't BIEL tell us? The tone of the June 8th update certainly implied that the meetings were "one and done."
2. If a second FDA meeting was NOT requested by BIEL at that time, why was the second meeting necessary? What did the FDA tell BIEL that caused BIEL to request another meeting with the FDA?
3. WHY won't BIEL tell us the FDA's pathway decision?
It's not illegal to omit information from these company updates. It certainly is unethical, IMO.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM